Ming Zhou, Kanger Shen, Ziyi Huang, Qin Zhan, Jiayu Wang, Xiaozhe Mao, Tongguo Shi, Rui Li
{"title":"HIF-1α通过调节磷脂酰胆碱代谢促进胃癌细胞的限制性迁移。","authors":"Ming Zhou, Kanger Shen, Ziyi Huang, Qin Zhan, Jiayu Wang, Xiaozhe Mao, Tongguo Shi, Rui Li","doi":"10.1111/jcmm.70828","DOIUrl":null,"url":null,"abstract":"<p>Confined migration (CM) is a key step in the process of cancer cell metastasis. However, the molecular mechanisms underlying CM in gastric cancer (GC) remain unclear. Here, we found that CM-GC cells had remarkable metastatic and antiapoptotic capacities. Moreover, we observed that HIF-1α was highly expressed in CM-GC cells. HIF-1α knockdown reversed the enhanced metastatic and antiapoptotic capacities of CM-GC cells in vitro and in vivo. Mechanistically, HIF-1α enhanced the metastatic and antiapoptotic capacities of CM-GC cells through phosphatidylcholine (PC) synthesis. Importantly, the addition of L-α-phosphatidylcholine (L-α-PC), a natural PC, markedly increased the metastatic and antiapoptotic capacities of GC cells, similar to CM GC cells. In addition, we observed that increased HIF-1α protein expression was positively correlated with the expression of CEPT1, a key enzyme of PC synthesis, in GC tissue samples. Furthermore, high expression of HIF-1α and CEPT1 in GC tissues predicted poor prognosis in patients with GC. Overall, our study supports the crucial role of HIF-1α in the CM of GC cells and provides novel therapeutic targets and strategies for metastatic GC.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 18","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12436174/pdf/","citationCount":"0","resultStr":"{\"title\":\"HIF-1α Promotes the Confined Migration of Gastric Cancer Cells by Modulating Phosphatidylcholine Metabolism\",\"authors\":\"Ming Zhou, Kanger Shen, Ziyi Huang, Qin Zhan, Jiayu Wang, Xiaozhe Mao, Tongguo Shi, Rui Li\",\"doi\":\"10.1111/jcmm.70828\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Confined migration (CM) is a key step in the process of cancer cell metastasis. However, the molecular mechanisms underlying CM in gastric cancer (GC) remain unclear. Here, we found that CM-GC cells had remarkable metastatic and antiapoptotic capacities. Moreover, we observed that HIF-1α was highly expressed in CM-GC cells. HIF-1α knockdown reversed the enhanced metastatic and antiapoptotic capacities of CM-GC cells in vitro and in vivo. Mechanistically, HIF-1α enhanced the metastatic and antiapoptotic capacities of CM-GC cells through phosphatidylcholine (PC) synthesis. Importantly, the addition of L-α-phosphatidylcholine (L-α-PC), a natural PC, markedly increased the metastatic and antiapoptotic capacities of GC cells, similar to CM GC cells. In addition, we observed that increased HIF-1α protein expression was positively correlated with the expression of CEPT1, a key enzyme of PC synthesis, in GC tissue samples. Furthermore, high expression of HIF-1α and CEPT1 in GC tissues predicted poor prognosis in patients with GC. Overall, our study supports the crucial role of HIF-1α in the CM of GC cells and provides novel therapeutic targets and strategies for metastatic GC.</p>\",\"PeriodicalId\":101321,\"journal\":{\"name\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"volume\":\"29 18\",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12436174/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70828\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70828","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
HIF-1α Promotes the Confined Migration of Gastric Cancer Cells by Modulating Phosphatidylcholine Metabolism
Confined migration (CM) is a key step in the process of cancer cell metastasis. However, the molecular mechanisms underlying CM in gastric cancer (GC) remain unclear. Here, we found that CM-GC cells had remarkable metastatic and antiapoptotic capacities. Moreover, we observed that HIF-1α was highly expressed in CM-GC cells. HIF-1α knockdown reversed the enhanced metastatic and antiapoptotic capacities of CM-GC cells in vitro and in vivo. Mechanistically, HIF-1α enhanced the metastatic and antiapoptotic capacities of CM-GC cells through phosphatidylcholine (PC) synthesis. Importantly, the addition of L-α-phosphatidylcholine (L-α-PC), a natural PC, markedly increased the metastatic and antiapoptotic capacities of GC cells, similar to CM GC cells. In addition, we observed that increased HIF-1α protein expression was positively correlated with the expression of CEPT1, a key enzyme of PC synthesis, in GC tissue samples. Furthermore, high expression of HIF-1α and CEPT1 in GC tissues predicted poor prognosis in patients with GC. Overall, our study supports the crucial role of HIF-1α in the CM of GC cells and provides novel therapeutic targets and strategies for metastatic GC.
期刊介绍:
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.